Organization
Medicines Development for Global Health
4 clinical trials
Clinical trial
A Phase II, Randomized, Double-blind, Parallel Group Dose Finding Study of Single Oral Doses of Moxidectin in Adults With ScabiesStatus: Completed, Estimated PCD: 2022-02-28
Clinical trial
A Randomized, Double Blind, Parallel Trial in the Democratic Republic of Congo (DRC) Comparing the Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Treatment of OnchocerciasisStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Clinical trial
A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies.Status: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
A Randomized, Double Blind, Parallel Group Clinical Trial to Evaluate the Safety of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Treatment With AlbendazoleStatus: Recruiting, Estimated PCD: 2024-07-01